Bethany Sensenig Supernus Pharmaceuticals, Inc. (SUPN) insider trading activity

Bethany Sensenig is Director of SUPERNUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of SUPN, which is worth approximately $0. The most recent transaction as insider was on Aug 14, 2025, when has been sold 5,369 shares (Common Stock) at a price of $42.25 per share, resulting in proceeds of $226,840. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

n/a 12M change

Total Value Held $0

Bethany Sensenig Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Aug 14 2025	SELL Open market or private sale	$226,840 $42.25 p/Share	5,369 Reduced 100.0%	0 Common Stock
Feb 22 2025	BUY Grant, award, or other acquisition	-	5,369 Added 50.0%	5,369 Common Stock

Also insider at

NMTR

9 METERS BIOPHARMA, INC. Healthcare

Chief Financial Officer

KALV

KalVista Pharmaceuticals, Inc. Healthcare